CA2438330A1 - Methode pour le depistage precoce du cancer - Google Patents
Methode pour le depistage precoce du cancer Download PDFInfo
- Publication number
- CA2438330A1 CA2438330A1 CA002438330A CA2438330A CA2438330A1 CA 2438330 A1 CA2438330 A1 CA 2438330A1 CA 002438330 A CA002438330 A CA 002438330A CA 2438330 A CA2438330 A CA 2438330A CA 2438330 A1 CA2438330 A1 CA 2438330A1
- Authority
- CA
- Canada
- Prior art keywords
- cells
- dutt1
- cancer
- population
- binding agent
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Abandoned
Links
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
- C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
- C07K14/46—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates
- C07K14/47—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates from mammals
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P35/00—Antineoplastic agents
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
- C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
- C07K14/705—Receptors; Cell surface antigens; Cell surface determinants
- C07K14/70503—Immunoglobulin superfamily
Landscapes
- Health & Medical Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Organic Chemistry (AREA)
- General Health & Medical Sciences (AREA)
- Medicinal Chemistry (AREA)
- Proteomics, Peptides & Aminoacids (AREA)
- Biophysics (AREA)
- Biochemistry (AREA)
- Genetics & Genomics (AREA)
- Gastroenterology & Hepatology (AREA)
- Molecular Biology (AREA)
- Zoology (AREA)
- Toxicology (AREA)
- Immunology (AREA)
- Pharmacology & Pharmacy (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- General Chemical & Material Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- Public Health (AREA)
- Veterinary Medicine (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Cell Biology (AREA)
- Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
- Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
- Measuring Or Testing Involving Enzymes Or Micro-Organisms (AREA)
- Investigating Or Analysing Biological Materials (AREA)
Abstract
La présente invention concerne des procédés destinés au diagnostic, à l'imagerie et au traitement de cellules cancéreuses. L'invention concerne plus particulièrement l'utilisation d'une molécule suppresseur de tumeur qui est apparente à des densités supérieures sur des cellules cancéreuses que sur des cellules se divisant normalement pour le diagnostic, l'imagerie, la prophylaxie et le traitement du cancer.
Applications Claiming Priority (5)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
GB0123630.6 | 2001-10-02 | ||
GB0123630A GB0123630D0 (en) | 2001-10-02 | 2001-10-02 | cancer |
GB0127668.2 | 2001-11-19 | ||
GB0127668A GB0127668D0 (en) | 2001-11-19 | 2001-11-19 | Cancer |
PCT/GB2002/004445 WO2003029488A2 (fr) | 2001-10-02 | 2002-10-02 | Cancer |
Publications (1)
Publication Number | Publication Date |
---|---|
CA2438330A1 true CA2438330A1 (fr) | 2003-04-10 |
Family
ID=26246602
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
CA002438330A Abandoned CA2438330A1 (fr) | 2001-10-02 | 2002-10-02 | Methode pour le depistage precoce du cancer |
Country Status (4)
Country | Link |
---|---|
EP (1) | EP1432821A2 (fr) |
JP (1) | JP2005504307A (fr) |
CA (1) | CA2438330A1 (fr) |
WO (1) | WO2003029488A2 (fr) |
Families Citing this family (4)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CN101014860B (zh) * | 2004-03-31 | 2012-01-25 | 中外制药株式会社 | 抗-robo1抗体用于制备癌症治疗药物及相关诊断试剂盒 |
US8940488B2 (en) | 2004-03-31 | 2015-01-27 | Hiroyuki Aburatani | Cancer diagnosis and treatment of cancer using anti-robo 1 antibody |
JP5117765B2 (ja) | 2007-05-28 | 2013-01-16 | 国立大学法人 東京大学 | 抗robo1抗体を含むpet用腫瘍診断剤 |
WO2010131590A1 (fr) * | 2009-05-14 | 2010-11-18 | 国立大学法人 東京大学 | Agent diagnostique et agent thérapeutique pour des tumeurs |
Family Cites Families (2)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
WO1999020764A1 (fr) * | 1997-10-20 | 1999-04-29 | The Regents Of The University Of California | Robo : une famille de polypeptides et d'acides nucleiques impliques dans le guidage des nerfs |
JP2001523458A (ja) * | 1997-11-14 | 2001-11-27 | ザ リージェンツ オブ ザ ユニバーシティ オブ カリフォルニア | 神経細胞機能の調節方法 |
-
2002
- 2002-10-02 JP JP2003532701A patent/JP2005504307A/ja not_active Withdrawn
- 2002-10-02 WO PCT/GB2002/004445 patent/WO2003029488A2/fr not_active Application Discontinuation
- 2002-10-02 EP EP02765065A patent/EP1432821A2/fr not_active Withdrawn
- 2002-10-02 CA CA002438330A patent/CA2438330A1/fr not_active Abandoned
Also Published As
Publication number | Publication date |
---|---|
JP2005504307A (ja) | 2005-02-10 |
EP1432821A2 (fr) | 2004-06-30 |
WO2003029488A3 (fr) | 2003-07-03 |
WO2003029488A2 (fr) | 2003-04-10 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
KR102618312B1 (ko) | 항muc16 항체 및 그의 용도 | |
CA2598510C (fr) | Sparc mutant a deletion q3 et utilisations dudit polypeptide mutant | |
ES2308787T3 (es) | Antigenos de superficie de celular de mamiferos; reactivos relacionados. | |
JP3682926B2 (ja) | 多薬物耐性遺伝子 | |
EP2261242A1 (fr) | Enzyme aspartate-N-acétyltransférase, procédé de diagnostic et procédé thérapeutique | |
JPH09509570A (ja) | Mts−1遺伝子により転移性癌の診断 | |
JP2004113151A (ja) | 癌遺伝子及びその用途 | |
JP2007197439A (ja) | 中皮抗原及びそれを標的化するための方法及びキット | |
US20030086929A1 (en) | Treatment of prostate cancer by inhibitors of ATP synthase | |
KR20020073181A (ko) | Liv-1 관련 단백질, 이를 코딩하는 폴리뉴클레오티드및 암의 치료를 위한 그의 용도 | |
EP1351968B1 (fr) | Mutations dans la sous-unite alpha1 du canal sodique du gene neuronal, polypeptides associes, et traitement du syndrome gefs+ (epilepsie generalisee avec crises febriles +) | |
JP3779989B2 (ja) | リンパ抗原cd30 | |
WO2001096359A1 (fr) | Compositions, procedes et kits relatifs a des molecules du type resistine | |
CA2150789A1 (fr) | Serine/threonine kinase | |
JP4365583B2 (ja) | ノッチレセプターアゴニスト及び用途 | |
CA2438330A1 (fr) | Methode pour le depistage precoce du cancer | |
WO2007037245A1 (fr) | Polypeptide présentant une activité anti-angiogénique | |
AU2002329437A1 (en) | A method for the early detection of cancer | |
JP3911017B2 (ja) | 腫瘍遺伝子Int6のヌクレオチド配列及び推定アミノ酸配列 | |
JP2004534525A (ja) | uPAR変異体del4、del5およびdel4+5に対する単特異性のポリクローナル抗体の製法並びに診断および治療目的のためのその使用 | |
US20040191791A1 (en) | Novel mutation | |
JP2003116560A (ja) | 新規なポリペプチド及びそれをコードするポリヌクレオチド | |
CA2447958A1 (fr) | Facteurs activant l'hypoxie et utilisation de ces facteurs pour activer l'angiogenese et ameliorer les fonctions musculaires | |
US7087715B2 (en) | Human paris-1 antigen and nucleic acids: diagnostic and therapeutic uses | |
JP2004511758A (ja) | 大腸癌の診断、モニタリング、ステージング、イメージングおよび処置の方法 |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
FZDE | Dead |